Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma

BACKGROUND: Fluorine 18 ((18)F) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has limitations in staging hepatocellular carcinoma (HCC). The recently introduced (18)F-labeled fibroblast-activation protein inhibitor (FAPI) has shown promising prospects in detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Jiang, Shuqin, Li, Mengsi, Xue, Haibao, Zhong, Xi, Li, Shuyi, Peng, Hao, Liang, Jiuceng, Liu, Zhidong, Rao, Songquan, Chen, Haipeng, Cao, Zewen, Gong, Yuanfeng, Chen, Guoshuo, Zhang, Rusen, Zhang, Linqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614420/
https://www.ncbi.nlm.nih.gov/pubmed/37899452
http://dx.doi.org/10.1186/s40644-023-00626-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614420/
https://www.ncbi.nlm.nih.gov/pubmed/37899452
http://dx.doi.org/10.1186/s40644-023-00626-y

Ejemplares similares